Skip to content
A Model for Moving from Breakthrough to Blockbuster episode artwork

Mar 31, 2022 25 min

A Model for Moving from Breakthrough to Blockbuster

from The Bio Report Hosted by Levine Media Group

About 15 years ago, Harvard Business School professor Gary Pisano took at look at how small entrepreneurial biotechs fared against large and mature pharmaceutical companies and found the two sectors were about the same when it came to R&D productivity. Now, a new book From Breakthrough to Blockbuster: The Business of Biotechnology finds that the biotechnology industry is far more effective at bringing innovative therapies to market than Big Pharma and offers a prescription for large drug companies to decentralize decision-making to improve their ability to innovate. We spoke to venture investor and former biotech executive Don Drakeman, co-author of the book, about its findings, how decentralized decision-making can produce greater innovation, and lessons from COVID-19.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

A Model for Moving from Breakthrough to Blockbuster

0:00 25:29

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 25 minutes long.

When was this The Bio Report episode published?

This episode was published on March 31, 2022.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.